Abstract
Prostaglandin (PG) D2, the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, the lack of PGD2 (DP) receptor antagonists has limited the study of its essential roles in the disease state. Recent discoveries of several DP receptor antagonists, the development of the mutant mouse and the discovery of a second PGD2 receptor, CRTH2 (chemoattractant receptor-homologousmolecule expressed on Th2 cells) receptor, have revealed the crucial roles of PGD2 and CRTH2 receptors in allergic disorders. This review presents biological evidence that PGD2 plays an essential role in allergy disorders and discusses the therapeutic possibilities of recently reported PGD2 antagonists.
Keywords: pgd2, crth2, bwa868c, s-5751, ramatroban, indometahcin, eosinophil
Current Pharmaceutical Design
Title: Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases
Volume: 10 Issue: 28
Author(s): Susumu Mitsumori
Affiliation:
Keywords: pgd2, crth2, bwa868c, s-5751, ramatroban, indometahcin, eosinophil
Abstract: Prostaglandin (PG) D2, the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, the lack of PGD2 (DP) receptor antagonists has limited the study of its essential roles in the disease state. Recent discoveries of several DP receptor antagonists, the development of the mutant mouse and the discovery of a second PGD2 receptor, CRTH2 (chemoattractant receptor-homologousmolecule expressed on Th2 cells) receptor, have revealed the crucial roles of PGD2 and CRTH2 receptors in allergic disorders. This review presents biological evidence that PGD2 plays an essential role in allergy disorders and discusses the therapeutic possibilities of recently reported PGD2 antagonists.
Export Options
About this article
Cite this article as:
Mitsumori Susumu, Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases, Current Pharmaceutical Design 2004; 10 (28) . https://dx.doi.org/10.2174/1381612043382864
DOI https://dx.doi.org/10.2174/1381612043382864 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease
Current Gene Therapy Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry HPLC and MS Analysis for the Identification and Characterisation of Peptides Presented in the Context of the Non-Classical Human Leukocytes Antigen (HLA) Class I Molecule HLA-E
Current Pharmaceutical Design Selective Inhibitors of Hepatitis B Virus Replication
Current Medicinal Chemistry - Anti-Infective Agents Protein-Modified Magnetic Nanoparticles for Biomedical Applications
Current Organic Chemistry SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors
Current Pharmaceutical Design Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer
Current Medicinal Chemistry The Application of Phage Display in Allergy Research: Characterization of IgE, Identification of Allergens and Development of Novel Therapeutics
Current Pharmaceutical Biotechnology Genetics of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews A Purified Fraction of Ocimum tenuiflorum (L) Inhibits LTC4, LTA4 and COX-2 Activities, Down-Regulates mRNA Expression in HL-60 Cells and Reduces Lung Inflammation in an OVA Induced Asthma Model in BALB/c Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Atherosclerosis-Related Functions of C-Reactive Protein
Cardiovascular & Hematological Disorders-Drug Targets Emerging Therapeutic Effects of Herbal Plants in Rheumatoid Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Effect of Synthetic Cannabinoid HU210 on Memory Deficits and Neuropathology in Alzheimers Disease Mouse Model
Current Alzheimer Research Serum Uric Acid Level as a Predictive Biomarker of Gestational Hypertension Severity; A Prospective Observational Case-Control Study
Reviews on Recent Clinical Trials Using Current Data to Define New Approach in Age Related Macular Degeneration: Need to Accelerate Translational Research
Current Genomics An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry An Insight into Oligopeptide Transporter 3 (OPT3) Family Proteins
Protein & Peptide Letters Marine Lipids and the Bioavailability of <i>Omega</i>-3 Fatty Acids
Current Nutrition & Food Science Inflammatory Mechanisms of Adverse Reactions to Drug-Eluting Stents
Current Vascular Pharmacology